Status:
UNKNOWN
Intestinal Flora Research Plan for Critically Ill Patients
Lead Sponsor:
Chinese Medical Association
Conditions:
Gut Microbiota, PICS
Eligibility:
All Genders
18-75 years
Brief Summary
More and more critically ill patients have improved early survival, they have been suffering from organ damage and inflammation for a long time, which is called chronic critical illness (CCI). Among C...
Detailed Description
With the improvement and development of medical technology and concepts, the types, progression, and outcomes of critically ill patients have changed dramatically. More and more critically ill patient...
Eligibility Criteria
Inclusion
- Age 18-75 years old
- Expect to stay in the ICU for more than 7 days after enrollment;
- Initial disease, not receiving ICU special treatment;
Exclusion
- Does not meet the inclusion criteria;
- Complicated with perianal infection, intestinal fistula, short bowel syndrome, chronic severe gastrointestinal disease;
- Patients with malignant tumors undergoing chemotherapy and radiotherapy;
- Taking probiotic preparations within the past 3 months, etc. Intestinal flora regulator.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04455061
Start Date
January 1 2020
End Date
December 30 2022
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affliated Drum Tower Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, China, 210008